ContractProduct Rights Agreement • May 18th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
Dated 22 January 2018 Product Rights Agreement between Alvotech HF. and Alvogen Lux Holdings Sarl White & Case LLP 5 Old Broad Street London EC2N 1DWProduct Rights Agreement • February 7th, 2022 • Alvotech Lux Holdings S.A.S. • Biological products, (no disgnostic substances) • England and Wales
This PRODUCT RIGHTS AGREEMENT (this “Agreement”) is entered into as of 22 January 2018 (the “Effective Date”) by and among Alvotech hf., a public limited company incorporated under the laws of Iceland (“Alvotech”), and Alvogen Lux Holdings Sarl, a limited company established under the law of the Grand Duchy of Luxembourg (“Alvogen”).
Exhibit 10.15 AMENDMENT NO. 1 TO THE PRODUCT RIGHTS AGREEMENT This Amendment No. 1 ("Amendment No. 1") is made this 20th day of May, 1999 (the "Amendment Effective Date") by and between AMERICAN HOME PRODUCTS CORPORATION, a corporation organized and...Product Rights Agreement • March 7th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
Unaudited Pro Forma Condensed Consolidated Financial InformationProduct Rights Agreement • May 23rd, 2023 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments
ContractProduct Rights Agreement • February 7th, 2022 • Alvotech Lux Holdings S.A.S. • Biological products, (no disgnostic substances) • England and Wales
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].”
EXHIBIT 10.1 PRODUCT RIGHTS AGREEMENTProduct Rights Agreement • July 1st, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New Jersey
